Cases & Deals

  • Home
  • Practices
  • Bambusa Therapeutics closes upsized $168.9 million initial public offering

Share

Bambusa Therapeutics closes upsized $168.9 million initial public offering

November 2026

Client(s) Bambusa Therapeutics, Inc.

Jones Day served as IP counsel and represented Bambusa Therapeutics, Inc. ("Bambusa") in its upsized US$168.9 million initial public offering ("IPO") and listing on the Nasdaq Global Select Market under the ticker symbol "BBTX." Bambusa is a clinical-stage biopharmaceutical company developing next-generation, long-acting precision bispecific antibodies for immunology and inflammation.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.